References

1. Connor TH, MacKenzie BA, DeBord DG, et al. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings. Cincinnati, OH. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. 2016.
2. Sansom LN, ed. Australian pharmaceutical formulary and handbook. 2024. Compounding; [updated 2024 Feb 16]. At: https://apf.psa.org.au/compounding/good-compounding-practice-0
3. USP <800>: Hazardous drugs–handling in healthcare settings. Rockville, MD. United States Pharmacopeial Convention. 2016.
4. International Society of Oncology Pharmacy Practitioners. ISOPP Standards for the Safe Handling of Cytotoxics. J Oncol Pharm Practice 2022;28(3 (supplement)):1–126.
5. Victorian Therapeutic Advisory Group. Handling of Hazardous Medicines Victorian Framework. 2021. At: ,victag.org.au/VicTAG_Handling_of_Hazardous_Medicine_Framework_Nov_2021_Final.pdf
6. Easty AC, Coakley N, Cheng R et al. Safe handling of cytotoxics: guideline recommendations. Current oncology (Toronto, Ont.) 2015;22(1):e27–e37.